UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Replication Stress Response Links RAD52 to Protecting Common Fragile Sites

Cancers, 2019-09, Vol.11 (10), p.1467

Wu, Xiaohua

2019

Volltextzugriff (PDF)

Advances in diagnosis and treatment of metastatic cervical cancer

Journal of Gynecologic Oncology, 2016, 27(4), , pp.1-20

2016

Volltextzugriff (PDF)

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

Journal of clinical oncology, 2021-06, Vol.39 (17), p.JCO2100306-1855

2021

Volltextzugriff (PDF)

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2

Molecular cancer, 2021-03, Vol.20 (1), p.1-45, Article 45

2021

Volltextzugriff (PDF)

Simple conization and pelvic lymphadenectomy in early-stage cervical cancer: A retrospective analysis and review of the literature

Gynecologic oncology, 2020-08, Vol.158 (2), p.231-235

2020

Volltextzugriff (PDF)

Incidence, risk factors and treatment of cervical stenosis after radical trachelectomy: A systematic review

European journal of cancer (1990), 2015-09, Vol.51 (13), p.1751-1759

2015

Volltextzugriff (PDF)

Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients

BMC cancer, 2024-05, Vol.24 (1), p.565-11, Article 565

2024

Volltextzugriff (PDF)

LncRNA‐OG Promotes the Osteogenic Differentiation of Bone Marrow‐Derived Mesenchymal Stem Cells Under the Regulation of hnRNPK

Stem cells (Dayton, Ohio), 2019-02, Vol.37 (2), p.270-283

2019

Volltextzugriff (PDF)

Ovarian cancer circulating extracelluar vesicles promote coagulation and have a potential in diagnosis: an iTRAQ based proteomic analysis

BMC cancer, 2019-11, Vol.19 (1), p.1095-1095, Article 1095

2019

Volltextzugriff (PDF)

Recognition of Peripheral Lung Cancer and Focal Pneumonia on Chest Computed Tomography Images Based on Convolutional Neural Network

Technology in cancer research & treatment, 2022-03, Vol.21, p.15330338221085375-15330338221085375

2022

Volltextzugriff (PDF)

The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer

BMC cancer, 2018-09, Vol.18 (1), p.883-883, Article 883

2018

Volltextzugriff (PDF)

SALL4 as an indicator for the diagnosis of hepatoid carcinoma of the ovary: A case report and literature review

Clinical case reports, 2023-08, Vol.11 (8), p.e7706-n/a

2023

Volltextzugriff (PDF)

Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence

BMC cancer, 2023-05, Vol.23 (1), p.485-485

2023

Volltextzugriff (PDF)

Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer

International journal of gynecological cancer, 2021-01, Vol.31 (1), p.52-58

2021

Volltextzugriff (PDF)

Genomic profile of Chinese patients with endometrial carcinoma

BMC cancer, 2023-09, Vol.23 (1), p.1-888, Article 888

2023

Volltextzugriff (PDF)

Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer

BMC cancer, 2022-05, Vol.22 (1), p.550-550, Article 550

2022

Volltextzugriff (PDF)

Clinical Significance of Programmed Death Ligand‑1 and Intra-Tumoral CD8+ T Lymphocytes in Ovarian Carcinosarcoma

PloS one, 2017-01, Vol.12 (1), p.e0170879-e0170879

2017

Volltextzugriff (PDF)

Identification of Somatic Genetic Alterations Using Whole-Exome Sequencing of Uterine Leiomyosarcoma Tumors

Frontiers in oncology, 2021-06, Vol.11, p.687899-687899

2021

Volltextzugriff (PDF)

PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer

Molecular cancer, 2024-05, Vol.23 (1), p.111-111, Article 111

2024

Volltextzugriff (PDF)

Primary extramammary Paget's disease of the vulva: The clinicopathological features and treatment outcomes in a series of 43 patients

Gynecologic oncology, 2013-05, Vol.129 (2), p.412-416

2013

Volltextzugriff (PDF)

Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma

Journal of Gynecologic Oncology, 2017, 28(6), , pp.1-14

2017

Volltextzugriff (PDF)

Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer

PloS one, 2016-05, Vol.11 (5), p.e0156101-e0156101

2016

Volltextzugriff (PDF)

Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001

International journal of gynecological cancer, 2022-01, Vol.32 (1), p.93-100

2022

Volltextzugriff (PDF)

Anlotinib in Chinese Patients With Recurrent Advanced Cervical Cancer: A Prospective Single-Arm, Open-Label Phase II Trial

Frontiers in oncology, 2021-11, Vol.11, p.720343-720343

2021

Volltextzugriff (PDF)

Efficacy and safety of chiauranib in a combination therapy in platinum-resistant or refractory ovarian cancer: a multicenter, open-label, phase Ib and II study

Molecular cancer, 2024-08, Vol.23 (1), p.162-8, Article 162

2024

Volltextzugriff (PDF)

1 – 25 von 311

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(264)
Mit Volltextzugriff
(285)

Publikationsform

Artikel
(311)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Replication Stress Response Links RAD52 to Protecting Common Fragile Sites

Advances in diagnosis and treatment of metastatic cervical cancer

Atezolizumab, Bevacizumab, and Chemotherapy for Newly Diagnosed Stage III or IV Ovarian Cancer: Placebo-Controlled Randomized Phase III Trial (IMagyn050/GOG 3015/ENGOT-OV39)

FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2

Simple conization and pelvic lymphadenectomy in early-stage cervical cancer: A retrospective analysis and review of the literature

Incidence, risk factors and treatment of cervical stenosis after radical trachelectomy: A systematic review

Prognostic factors and the role of primary debulking in operable stage IVB ovarian cancer with supraclavicular lymph node metastasis: a retrospective study in Chinese patients

LncRNA‐OG Promotes the Osteogenic Differentiation of Bone Marrow‐Derived Mesenchymal Stem Cells Under the Regulation of hnRNPK

Ovarian cancer circulating extracelluar vesicles promote coagulation and have a potential in diagnosis: an iTRAQ based proteomic analysis

Recognition of Peripheral Lung Cancer and Focal Pneumonia on Chest Computed Tomography Images Based on Convolutional Neural Network

The preoperative prognostic nutritional index is a predictive and prognostic factor of high-grade serous ovarian cancer

SALL4 as an indicator for the diagnosis of hepatoid carcinoma of the ovary: A case report and literature review

Developing a nomogram for preoperative prediction of cervical cancer lymph node metastasis by multiplex immunofluorescence

Role of adjuvant therapy after radical hysterectomy in intermediate-risk, early-stage cervical cancer

Genomic profile of Chinese patients with endometrial carcinoma

Homologous recombination deficiency in diverse cancer types and its correlation with platinum chemotherapy efficiency in ovarian cancer

Clinical Significance of Programmed Death Ligand‑1 and Intra-Tumoral CD8+ T Lymphocytes in Ovarian Carcinosarcoma

Identification of Somatic Genetic Alterations Using Whole-Exome Sequencing of Uterine Leiomyosarcoma Tumors

PARP1-DOT1L transcription axis drives acquired resistance to PARP inhibitor in ovarian cancer

Primary extramammary Paget's disease of the vulva: The clinicopathological features and treatment outcomes in a series of 43 patients

Prognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma

Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer

Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001

Anlotinib in Chinese Patients With Recurrent Advanced Cervical Cancer: A Prospective Single-Arm, Open-Label Phase II Trial

Efficacy and safety of chiauranib in a combination therapy in platinum-resistant or refractory ovarian cancer: a multicenter, open-label, phase Ib and II study

Aktive Filter

Suchergebnisse filtern